ArticleCancer immunology, immunotherapy : CII2020

A phase I study of multi-HLA-binding peptides derived from heat shock protein 70/glypican-3 and a novel combination adjuvant of hLAG-3Ig and Poly-ICLC for patients with metastatic gastrointestinal cancers: YNP01 trial.

Masao Nakajima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.